Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study

Abstract Introduction The 2010 release of an abuse deterrent formulation (ADF) of OxyContin, a brand name prescription opioid, has been cited as a major driver for the reduction in prescription drug misuse and the associated increasing illicit opioid use and overdose rates. However, studies of this...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Eric W. Lundstrom, Zheng Dai, Caroline P. Groth, Brian Hendricks, Erin L. Winstanley, Marie Abate, Gordon S. Smith
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: BMC 2024-01-01
Loạt:Substance Abuse Treatment, Prevention, and Policy
Những chủ đề:
Truy cập trực tuyến:https://doi.org/10.1186/s13011-023-00587-2